Fifth Third Bancorp Novo Nordisk A S Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Novo Nordisk A S stock. As of the latest transaction made, Fifth Third Bancorp holds 48,414 shares of NVO stock, worth $4.12 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

48,414

Previous 52,984 8.63%

Holding current value

$4.12 Million

Previous $7.56 Million 23.78%

% of portfolio

0.02%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$119.07 - $145.42 $544,149 - $664,569	-4,570 Reduced 8.63%	48,414 $5.76 Million
Q2 2024 Jul 22, 2024	SELL	$122.71 - $146.91 $69,331 - $83,004	-565 Reduced 1.06%	52,984 $7.56 Million
Q1 2024 Apr 23, 2024	SELL	$102.11 - $135.92 $307,248 - $408,983	-3,009 Reduced 5.32%	53,549 $6.88 Million
Q4 2023 Jan 19, 2024	SELL	$87.78 - $105.45 $277,999 - $333,960	-3,167 Reduced 5.3%	56,558 $5.85 Million
Q3 2023 Oct 31, 2023	BUY	$90.94 - $199.54 $2.59 Million - $5.68 Million	28,466 Added 91.06%	59,725 $5.43 Million
Q2 2023 Jul 25, 2023	SELL	$155.98 - $172.65 $1.36 Million - $1.5 Million	-8,700 Reduced 21.77%	31,259 $5.06 Million
Q1 2023 Apr 24, 2023	BUY	$132.34 - $159.14 $39,569 - $47,582	299 Added 0.75%	39,959 $6.36 Million
Q4 2022 Jan 25, 2023	SELL	$102.55 - $135.33 $46,352 - $61,169	-452 Reduced 1.13%	39,660 $0
Q3 2022 Oct 25, 2022	SELL	$95.28 - $116.93 $979,764 - $1.2 Million	-10,283 Reduced 20.4%	40,112 $4 Million
Q2 2022 Aug 04, 2022	SELL	$103.24 - $121.81 $339,659 - $400,754	-3,290 Reduced 6.13%	50,395 $5.62 Million
Q1 2022 Apr 19, 2022	SELL	$93.1 - $112.54 $124,102 - $150,015	-1,333 Reduced 2.42%	53,685 $5.96 Million
Q4 2021 Feb 01, 2022	SELL	$95.88 - $117.08 $370,576 - $452,514	-3,865 Reduced 6.56%	55,018 $6.16 Million
Q3 2021 Oct 15, 2021	SELL	$84.42 - $106.62 $189,100 - $238,828	-2,240 Reduced 3.66%	58,883 $5.65 Million
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $166,714 - $208,848	2,464 Added 4.2%	61,123 $5.12 Million
Q1 2021 May 07, 2021	BUY	$67.06 - $75.82 $31,115 - $35,180	464 Added 0.8%	58,659 $3.96 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $130,335 - $150,552	2,040 Added 3.63%	58,195 $4.07 Million
Q3 2020 Nov 09, 2020	SELL	$63.69 - $70.22 $53,117 - $58,563	-834 Reduced 1.46%	56,155 $3.9 Million
Q2 2020 Aug 05, 2020	SELL	$58.54 - $67.94 $18,498 - $21,469	-316 Reduced 0.55%	56,989 $3.73 Million
Q1 2020 May 05, 2020	SELL	$49.46 - $64.78 $59,302 - $77,671	-1,199 Reduced 2.05%	57,305 $3.45 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $120,461 - $140,756	-2,416 Reduced 3.97%	58,504 $3.39 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $97,076 - $109,104	-2,042 Reduced 3.24%	60,920 $3.15 Million
Q2 2019 Aug 07, 2019	BUY	$46.79 - $52.47 $92,457 - $103,680	1,976 Added 3.24%	62,962 $3.21 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $59,387 - $67,419	-1,281 Reduced 2.06%	60,986 $3.19 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $39,587 - $45,029	-953 Reduced 1.51%	62,267 $2.87 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $73,880 - $80,959	-1,580 Reduced 2.44%	63,220 $2.98 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $110,016 - $125,243	-2,484 Reduced 3.69%	64,800 $2.99 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $3.8 Million - $4.55 Million	-78,320 Reduced 53.79%	67,284 $3.31 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $127,950 - $144,641	-2,692 Reduced 1.82%	145,604 $7.82 Million
Q3 2017 Nov 14, 2017	SELL	$41.15 - $49.22 $202,704 - $242,457	-4,926 Reduced 3.21%	148,296 $7.14 Million
Q2 2017 Aug 11, 2017	BUY	N/A	153,222	153,222 $6.57 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Novo Nordisk A S Transaction History